Byrne Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15K | Hold |
56
| – | – | ﹤0.01% | 503 |
|
|
2025
Q1 | $2.17K | Hold |
56
| – | – | ﹤0.01% | 520 |
|
|
2024
Q4 | $1.89K | Hold |
56
| – | – | ﹤0.01% | 508 |
|
|
2024
Q3 | $2.29K | Sell |
56
-90
| -62% | -$3.68K | ﹤0.01% | 499 |
|
|
2024
Q2 | $5.64K | Buy |
146
+90
| +161% | +$3.48K | ﹤0.01% | 436 |
|
|
2024
Q1 | $2.4K | Hold |
56
| – | – | ﹤0.01% | 486 |
|
|
2023
Q4 | $2.08K | Hold |
56
| – | – | ﹤0.01% | 494 |
|
|
2023
Q3 | $2K | Hold |
56
| – | – | ﹤0.01% | 474 |
|
|
2023
Q2 | $2K | Hold |
56
| – | – | ﹤0.01% | 541 |
|
|
2023
Q1 | $2K | Buy |
+56
| New | +$2K | ﹤0.01% | 546 |
|
|
2022
Q3 | – | Sell |
-82
| Closed | -$4K | – | 509 |
|
|
2022
Q2 | $4K | Buy |
+82
| New | +$4K | ﹤0.01% | 447 |
|